Moreover, bilirubin inhibited the sorafenib-mediated decrease in the percentage of HCC cells positive for Ki-67, a cell proliferation marker (P < 0.05) (Figure 6E). The gene discussed is MKI67; the disease is hepatocellular carcinoma.